Latest news for NYLI Cleaner Transport ETF (ARCA:CLNR)

Technology

Consumer Cyclical

Industrials

Utilities

Other

Basic Materials

The Fund employs a passive management or indexing investment approach designed to track the performance of the Underlying Index, which was developed by IndexIQ LLC (IndexIQ) with Candriam Belgium S.A. (Candriam) acting as index consultant to IndexIQ. The Underlying Index incorporates thematic selection criteria designed to provide exposure to equity securities of companies that support the transition to more environmentally efficient transportation technologies, such as electric vehicles, bicycles, motor vehicle parts manufacturers, and multi-passenger transportation. The Underlying Index includes companies engaged in renewable energy production, sustainable mining for battery resources, vehicle production and sustainable transportation infrastructure. Companies selected for inclusion in the Underlying Index offer, support or enable cleaner transportation products and services. A company included in the Underlying Index is not required to be primarily or even directly engaged in activities that protect or achieve cleaner transportation technologies. The Underlying Index includes thematic selection criteria developed by IndexIQ and Candriam that reflect initiatives, research and programs of the National Wildlife Federation (NWF), a 501(c)(3) public charity. The Underlying Index includes securities of large-, mid- and small-capitalization companies that trade in the U.S. and foreign markets, including emerging markets other than China, Egypt, India, Kuwait, Pakistan, Qatar, Saudi Arabia and United Arab Emirates. The index universe consists of approximately the largest 99% of the free-float market capitalization in the global markets. As of September 30, 2021, the market capitalization range of the Underlying Index was approximately $1.0 billion to $1.8 trillion. As of September 30, 2021, the primary sectors within the Underlying Index are consumer discretionary, industrials and information technology.

Taiwan Semiconductor Manufacturing Co. Ltd.

Nvidia Corp Nvda Uw Equity Us Usd

Tesla, Inc.

Apple Inc

Hitachi Ltd

Byd Co Ltd H

Alphabet, Inc. - Class a

ABB Limited

Intel Corp.

Texas Instruments Inc

IQ Cleaner Transport ETF

NYLI Cleaner Transport ETF

Piper Sandler analyst Paul Newsome upgrades Arthur J. Gallagher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) from Neutral to Overweight and raises the price target from $285 to $315.

News

Upgrades

Price Target

Analyst Ratings

Piper Sandler Upgrades Arthur J. Gallagher to Overweight, Raises Price Target to $315

JP Morgan analyst Marcelo Santos maintains MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) with a Neutral and lowers the price target from $2150 to $1950.

MELI

JP Morgan Maintains Neutral on MercadoLibre, Lowers Price Target to $1950

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

Currenc Group Announced The Launch Of Its Seamless Ai Call Centre Solutions, A Suite Of AI-powered Tools Designed To Reduce Costs, Increase Efficiency And Boost Customer Satisfaction

GRMN

Garmin Announced A New Montana Series – The Montana 710, Montana 710i And Robust Montana 760i – To Its Collection Of Handheld GPS Navigators

VK2375 is being developed in both oral and subcutaneous formulations for the potential treatment of various metabolic disorders such as obesity.

VKTX

Viking Therapeutics Initiates Phase 2 Clinical Trial Of The Oral Tablet Formulation Of VK2735

JMP Securities analyst Silvan Tuerkcan initiates coverage on Context Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTX#NASDAQ">CNTX</a>) with a Market Outperform rating and announces Price Target of $4.

Initiation

CNTX

JMP Securities Initiates Coverage On Context Therapeutics with Market Outperform Rating, Announces Price Target of $4

BFLY

Butterfly Network Announced That It Expects To Report Revenue Growth For The Fourth Quarter Ended December 31, 2024 Of Approximately 35% Year Over Year

<ul>
<li>Provides 2025 Annual Guidance of $178 - $182 Million in Revenue and $38 -&nbsp;$42 Million of Adjusted EBITDA, Representing Year-Over-Year Increase of 13% in Revenues and 19% in Adjusted EBITDA Based on Mid-Point of 2024 Annual Guidance</li>
<li>Expects to Achieve 2024 Guidance of $158 - $162 Million in Revenue and $32 - $35 Million of Adjusted EBITDA; 2024 Year-End Cash of $78 Million</li>
<li>Aiming to Secure New Business Development and M&amp;A Transactions During 2025 that Leverage Overall Financial Strength and Existing Commercial Infrastructure to Accelerate Long-Term Growth</li>
<li>Expansion of Plasma Collection Operations with Opening of a Third Center by End of Q1 2025</li>
<li>Based on Positive Feedback from U.S. FDA, Kamada Plans to Reduce Inhaled AAT Clinical Study Sample Size to Approximately 180 Patients; Interim Futility Analysis Planned by End of 2025</li>
</ul>

Guidance

KMDA

Kamada Reaffirms 2024 Targets, Unveils 2025 Guidances, Revenue Of $178M-$182M Vs. $171.18M Est. And Adj.EBITDA Of $38M-$42M

The aggregate gross proceeds to uniQure from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by uniQure, are expected to be approximately $75 million.&nbsp;

Offerings

QURE

uniQure Prices Public Offering Of 4.41M Of Its Ordinary Shares At $17.00 Per Share

HALO

Halozyme Raises 2025 Financial Guidance Ranges For Total Revenue To $1.150B - $1.225B From $1.095B to $1.170B (Vs. Cons. Of $1.156B), Adj. EPS To $4.95 - $5.35 From $4.45 to $4.85 (Vs. Cons. $4.83)

As the planned purchases are to be executed by Wei Fu&nbsp;via his controlled entity, I-Mab cannot guarantee the number of ADSs to be purchased or the time frame in which the ADSs will be bought in the open market.

IMAB

I-Mab Chairman Wei Fu Informs His Intent To Purchase Up To $2M Of Company's American Depository Shares

The clinical program for sonelokimab now includes patients with adolescent hidradenitis suppurativa, palmoplantar pustulosis, and axial spondyloarthritis, in addition to adult patients with HS and active psoriatic arthritis.&nbsp;
This increases the number of clinical trials led by MoonLake to ten and aligns with the plan to enroll over 3,000 patients in clinical trials with sonelokimab since the Company was founded in 2021.

Biotech

Health Care

General

MLTX

MoonLake Immunotherapeutics Announced That Patients Have Been Screened In Three New Trials Across Three New Indications To Evaluate Sonelokimab To Treat Inflammatory Disease

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Piper Sandler analyst Clarke Jeffries upgraded the rating for Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) from Neutral to Overweight and raised the price target from $311 to $357. Autodesk shares closed at $290.82 on Tuesday. <a href="https://www.benzinga.com/quote/ADSK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Deutsche Bank analyst Brian Bedell upgraded Nasdaq, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) from Hold to Buy and raised the price target from $80 to $98. Nasdaq shares closed at $76.36 on Tuesday. <a href="https://www.benzinga.com/quote/NDAQ/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst John Lovallo upgraded the rating for PulteGroup, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) from Neutral to Buy but lowered the price target from $154 to $148. PulteGroup shares closed at $107.83 on Monday. <a href="https://www.benzinga.com/quote/PHM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Michael Sison upgraded RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) from Equal-Weight to Overweight and raised the price target from $134 to $140. RPM shares closed at $121.74 on Tuesday. <a href="https://www.benzinga.com/quote/RPM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho analyst Siti Panigrahi upgraded Twilio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) from Neutral to Outperform and raised the price target from $85 to $140. Twilio shares closed at $109.82 on Tuesday. <a href="https://www.benzinga.com/quote/TWLO/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NDAQ stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="578" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08070637/image-44-1024x578.png" alt="" class="wp-image-723783" style="width:714px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08070637/image-44-1024x578.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08070637/image-44-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08070637/image-44-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08070637/image-44.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/42846607/bank-of-new-york-mellon-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Bank of New York Mellon Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Pre-Market Outlook

Trading Ideas

ADSK

NDAQ

TWLO

This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Despite finding some footing in 2024, the lithium market's main concerns, oversupply and slower-than-expected <a target="_blank" href="https://www.benzinga.com/electric-vehicles" rel="noreferrer noopener">electric vehicle (EV) adoption</a> could persist this year.
"This swing supply dynamic could serve as a cap on price increases in 2025, as rapid restarts may lead to a more oversupplied market than currently forecast," Federico Gay, principal lithium analyst at Benchmark Mineral Intelligence said, according to the <a target="_blank" href="https://www.bnnbloomberg.ca/business/international/2025/01/08/stubbornly-resilient-lithium-supply-remains-hurdle-to-recovery/" rel="noreferrer noopener">BNN Bloomberg's report</a>.
Current analyst projections estimate lithium carbonate prices will stabilize around $10,685 per ton in 2025. As prices have dropped over 80% since 2022, the market's "invisible hand" stepped in.
Suspended outputs and delayed expansion plans helped lithium regain its footing, but significant rebounds remain unlikely.
BloombergNEF recently downgraded its EV adoption forecast, citing geopolitical and economic uncertainties.
Donald Trump's return to the U.S. presidency has shifted policy focus back to fossil fuels, which may further dampen demand for battery metals.
Despite these headwinds, China has solidified its position in the lithium market, raising its reserves from 6% to 16.5% of the global total, making it the second-largest global market.
New reserves include spodumene mines in Tibet and lithium salt lakes in the Qinghai-Tibet Plateau—now the third largest in the world. With a low-cost alternative, China aims to reduce reliance on imports and further strengthen its influence on the EV market.
Yet, the U.S. is quietly growing its reserves, with Nevada in the center.
Lithium Americas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAC#NYSE">LAC</a>) has significantly increased reserves at its Thacker Pass project near the Nevada-Oregon border, with proven and probable reserves jumping 286% (since 2022) to 14.3 million tons of lithium carbonate equivalent (LCE).
The project's expanded lifespan and increased capacity position it as a critical supplier for General Motors' EV production. Lithium Americas also appointed Luke Colton as CFO to guide the project's development, which is set to commence later this decade.
Meanwhile, Nevada Lithium's (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/NVLHF#OTCQB">NVLHF</a>) Bonnie Claire project has made remarkable progress. The company <a target="_blank" href="https://nevadalithium.com/news-release/nevada-lithium-to-commence-trading-on-tsx-venture-exchange/" rel="noreferrer noopener">announced</a> a 68% increase in inferred resources at its Lower Zone, now holding 25.6 Mt of LCE at an average grade of 3,085 ppm lithium.
This development represents a threefold improvement in grade compared to prior estimates, with additional high-grade boron resources adding further value. The company was recently listed on the Toronto Venture Stock Exchange, where it trades under the ticker NVLH.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/01/42840568/chiles-codelco-targets-turnaround-with-modest-copper-output-increase-and-strategic-lithium-ventures" target="_blank" rel="noreferrer noopener">Chile's Codelco Targets Turnaround with Modest Copper Output Increase and Strategic Lithium Ventures</a></li>
</ul>
Photo via Shutterstock

Commodities

Markets

Media

NVLHF

Lithium Woes Spillover Into 2025, But US And China Quietly Build Reserves

ABSI

Absci, AMD Announce Strategic Collaboration; AMD To Also Make $20M Investment In Absci, Structured As Private Investment In Public Equity

EDAP

EDAP TMS Announced That The First Patient Has Been Treated In Phase 1/2 PULS Trial Evaluating Proprietary High-Intensity Focused Ultrasound Technology For Pancreatic Tumors

Halozyme Reports Preliminary Results, Reiterated Full Year 2024 Financial Guidance

SMPL

The Simply Good Foods Company Sees FY25 Net Sales To Increase 8.5%-10.5%, Adjusted EBITDA Expected To Increase 4%-6%

FUFU

BitFuFu Launches New Software Service, BitFuFuOS, Which Can Increase Mining Overall Earnings By Up To 20%

AIRI

Air Industries Land $5.9M Contract For F-5/T-38 Aircraft Actuators

Sector Insights: What Could Go Right In 2024?

Amid The Noise: Four U.S. Value Equity Themes To Monitor

AGGY

AGNG

AIRR

ANEW

ARKF

ARKG

ARKQ

ARKW

ARKX

AVIG

BATT

BBAG

BDCZ

BIZD

BKAG

BLCN

BLOK

BMED

BNDC

BOIL

BOND

BTEC

BTEK

BYLD

CHRG

CIBR

CLNR

CLOU

CMBS

CNCR

DAPP

DFNL

DPST

DTEC

DUSL

EAGG

EDOC

ESGB

ESPO

EUSB

FBND

FDIS

FDRV

FFIU

FHLC

FIBR

FIDU

FIGB

FINX

FITE

FIXD

FLCB

FLGV

FNCL

FNGS

FSEC

FTEC

FTXH

FTXL

FTXO

FTXR

GAMR

GBUY

GCOR

GERM

GINN

GNMA

GNOM

GOVT

HACK

HART

HCRB

HELX

HERO

HTAB

HTEC

HTRB

IBBQ

IDGT

IDNA

IDRV

IEDI

IETC

IGPT

IHAK

ILDR

IMTB

IRBO

ITEQ

IUSB

IZRL

JCPB

JJETF

JJNTF

JMBS

KARS

KBWB

KBWD

KBWP

KBWR

KNCT

KOIN

LABU

LEGR

LITP

LOUP

LRNZ

MBSD

MDEV

MOON

MOTO

MTGP

Comments

NYLI Cleaner Transport ETF

News

Latest news for NYLI Cleaner Transport ETF (ARCA:CLNR)

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga